Home > Healthcare > Medical Devices > Diagnostic Devices > Ophthalmic Ultrasound Systems Market
Based on product, the ophthalmic ultrasound systems market is segmented into A-scan, B-scan, combined, pachymeter, and ultrasound bio microscope. The A-scan segment held the largest revenue size over USD 260 million in 2022 and is estimated to witness significant growth more than USD 400 million by 2032. The primary drivers predicted to stimulate the segment growth is the widespread use of A-scan equipment for pre-operative visualisation of a separated retina in cases such vitreous haemorrhage, peri-orbital trauma, or lens opacification. A-scan ultrasound is an essential tool in cataract surgery. It provides accurate measurements of the axial length of the eye, which is crucial for selecting the appropriate intraocular lens (IOL) power. Additionally, A-scan also makes use of innovative transducer and electronic technology, that greatly improves reliability and accuracy in ophthalmic procedures.
Ophthalmic ultrasound systems market is bifurcated based on the application including standalone and portable. The standalone segment dominated the market and is anticipated to grow over USD 700 million by 2032. Standalone ophthalmic ultrasound systems provide real-time imaging capabilities, particularly with B-scan ultrasound. This allows ophthalmologists to visualize the eye structures dynamically, assess their movement, and capture any changes that may occur over time. Standalone ophthalmic ultrasound systems are often designed to be portable, compact, and easily transportable. Such point of care ultrasound devices allow for convenient use in different clinical settings, including operating rooms, emergency departments, and remote locations.
The market is segmented by end-use into hospitals, ambulatory surgical Centers, ophthalmic clinic, and others. Hospitals segment dominated the global ophthalmic ultrasound systems market accounting for more than 37% market share in 2022 and is estimated to witness significant revenue over USD 500 million by 2032. The high segment growth is attributable to the increasing use of diagnostic imaging systems due to the rise in number of individuals suffering from eye disorders. Moreover, favourable government policies promoting the development of eye care facilities in various geographies. Furthermore, a vast patient pool, the availability of improved technology, and attractive government initiatives are expected to fuel segment expansion in the coming years.
U.S. ophthalmic ultrasound systems market accounted for more than USD 250 million in 2022 and will grow momentously more than USD 400 million by 2032. The growth is majorly due to the growing demand for ophthalmic devices with cutting-edge technology, including A-scan, B-scan, and integrated devices. Additionally, the rising prevalence of eye disorders, such as cataracts, glaucoma, retinal detachments, and ocular tumors, has driven the demand for ophthalmic ultrasound systems in U.S. As the population ages, the incidence of these conditions increases, leading to a greater need for advanced diagnostic and optical imaging technologies. Thus, growing geriatric population base has further contributed to impel the adoption of ophthalmic ultrasound systems technologies.